Is First Trust Amex Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, First Trust Amex Biotech pays dividends. Last time was Monday 10th of January 2022 where the investors holding the stock on Thursday 30th of December 2021 were paid $2.214 per share. Over the last 6 times between 2008 and 2021, First Trust Amex Biotech has paid $2.669 with an average of $0.44 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for First Trust Amex Biotech 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $126.81, you would have made a profit of $37.81 per share or 29.82%
Yes, the average daily trading liquidity for First Trust Amex Biotech is $24 125 thousand. You should therefore be able to get in and out of your positions relatively fast.
First Trust Amex Biotech has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for First Trust Amex Biotech to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.